Augurex Expands JOINTstat® RA Diagnostic Test Availability with MitogenDx

Augurex Expands JOINTstat® RA Diagnostic Test Availability with MitogenDx

Augurex Life Sciences Corp., a leading innovator in autoimmune-based diagnostics, today announced a strategic partnership with MitogenDx, a Canadian specialty laboratory focused on autoimmune and rheumatology testing. Under the agreement, MitogenDx will offer Augurex’s JOINTstat® blood test, significantly expanding access…

Read More Augurex Expands JOINTstat® RA Diagnostic Test Availability with MitogenDx
Next Health Forms Scientific Advisory Council to Advance Longevity and Proactive Healthcare

Next Health Forms Scientific Advisory Council to Advance Longevity and Proactive Healthcare

Next Health, recognized globally as a leader in health optimization and longevity medicine, has officially launched its Scientific Advisory Council—a distinguished assembly of physicians, scientists, and innovators committed to shaping the future of proactive healthcare. Led by Founder and CEO…

Read More Next Health Forms Scientific Advisory Council to Advance Longevity and Proactive Healthcare
Frontier Scientific Solutions and ATSG Partner to Launch Life Sciences Air Services

Frontier Scientific Solutions and ATSG Partner to Launch Life Sciences Air Services

Frontier Scientific Solutions (Frontier) and Air Transport Services Group, Inc. (ATSG) have announced a landmark strategic partnership aimed at redefining the global delivery of temperature-sensitive pharmaceuticals. The collaboration introduces a purpose-built air corridor exclusively designed for life sciences, ensuring uninterrupted…

Read More Frontier Scientific Solutions and ATSG Partner to Launch Life Sciences Air Services

Tubulis Secures €308M Series C to Advance Lead ADC TUB-040 and Pipeline Expansion

Tubulis, a leading biotechnology company focused on developing next-generation antibody-drug conjugates (ADCs), today announced the successful closing of a €308 million (USD 361 million) Series C financing round — one of the largest private financings in the European biotech sector…

Read More Tubulis Secures €308M Series C to Advance Lead ADC TUB-040 and Pipeline Expansion
Orum Therapeutics Appoints Dr. Dorin Toader to Lead Platform Technology

Orum Therapeutics Appoints Dr. Dorin Toader to Lead Platform Technology and Advance Degrader–Antibody Conjugates

Orum Therapeutics, a public biotechnology company pioneering the development of degrader–antibody conjugates (DACs), has announced the appointment of Dorin Toader, Ph.D., as Head of Platform Technology. With over 27 years of experience in drug discovery and more than 15 years…

Read More Orum Therapeutics Appoints Dr. Dorin Toader to Lead Platform Technology and Advance Degrader–Antibody Conjugates
nsitro Expands Collaboration with Bristol Myers Squibb Using ChemML Platform

nsitro Expands Collaboration with Bristol Myers Squibb Using ChemML Platform

insitro, a leading machine learning–driven drug discovery and development company, has announced the next phase of its ongoing collaboration with Bristol Myers Squibb (NYSE: BMY) to develop novel therapeutics for amyotrophic lateral sclerosis (ALS). The collaboration extension deepens the partnership’s…

Read More nsitro Expands Collaboration with Bristol Myers Squibb Using ChemML Platform
Farmland LP, Carbon Friendly Submit First U.S. Regenerative Farming Carbon Credits to Verra

Farmland LP, Carbon Friendly Submit First U.S. Regenerative Farming Carbon Credits to Verra

Farmland LP, the largest U.S. manager exclusively focused on organic and regenerative farmland, together with Carbon Friendly, a leading developer of regenerative carbon projects, have achieved a major milestone in the voluntary carbon market. The two organizations have submitted the…

Read More Farmland LP, Carbon Friendly Submit First U.S. Regenerative Farming Carbon Credits to Verra